The Translational Genomics Research Institute (TGen), an affiliate of City of Hope, is partnering with a Silicon Valley firm to become one of the first research institutes in the world to employ a new ...

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always ...

PHOENIX, Ariz. -- April 13, 2021 -- Findings of a study by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest that increasing expression of a gene known as ...

We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you ...

FLAGSTAFF, Ariz., and LUXEMBOURG CITY, Luxembourg -- Aug. 31 -- Advanced Biological Laboratories (ABL) is expected to soon begin manufacturing of a compact, portable and affordable test for ...

Since mid-January, the Translational Genomics Research Institute (TGen) has joined the world-wide effort to test for the SARS-CoV-2 virus causing the COVID-19 disease. Acting as Genomic First ...

PHOENIX — The Translational Genomics Research Institute (TGen) is now testing pets of Arizonans who have contracted COVID-19 in order to better track and understand the virus. "Among the more than 120 ...

Shares of Tecogen Inc. (TGEN Quick Quote TGEN - Free Report) have gained 20.5% over the past four weeks to close the last trading session at $5.36, but there could still be a solid upside left in the ...

FLAGSTAFF, Ariz. - The infectious disease division of TGen (Translational Genomics Research Institute) now finds itself in the middle of the investigation into the Coronavirus. The TGen branch in ...

In this complimentary podcast hear Dave Dimond, Chief Innovation Officer for Dell EMC Healthcare and Life Sciences as he speaks with James Lowey, Chief Information Officer for The Translational ...

Phoenix medical-research nonprofit TGen has licensed a blood-biopsy method to test for cancer to a for-profit public company in an effort to expand reach of the technology. Exact Sciences Corp. of ...

Tecogen Inc. (TGEN) closed the last trading session at $6.9, gaining 43.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall ...